Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMMC.L Regulatory News (MMC)

  • There is currently no data for MMC

SAR 3 - Management Consulting

22 Nov 2005 11:41

Schroders PLC22 November 2005 FORM SAR 3 DISCLOSURE OF ACQUISITIONS (Rule 3 of The Rules Governing Substantial Acquisitions of Shares) Name of acquirer Schroders plc Beneficial owner, if different from above Clients under discretionary management agreements with Schroder Investment Management Limited and its associates and subsidiaries. Names of any other persons acting by agreement n/aor understanding (see SAR 5) Company dealt in Management Consulting Group Class of voting shares (eg ordinary shares) Ord 25p Date of acquisition 21.11.05 Number of shares acquired 1,500,000 Number of rights over shares acquired # n/a Nature of rights over shares n/a Total holding of voting shares (and percentage 31,174,359 (16.451%)of total voting shares in issue) Total holding of rights over shares (and n/apercentage of total voting shares in issue) Combined total holding (and percentage) of 31,174,359 (16.451%)voting shares and rights over shares Date of disclosure 22.11.05 Contact name Albion Onojobi Telephone number 020 7658 2962 # See the definition of "rights over shares" in the Definitions Section of theSARs. For details of the SARs disclosure requirements, see SARs 3 and 5 and theirNotes which can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Jun 20205:30 pmRNSManagement Consulting Group
26th May 20201:24 pmRNSResult of AGM
21st May 20209:56 amRNSHolding(s) in Company
20th May 202012:06 pmRNSHolding(s) in Company
20th May 202012:05 pmRNSHolding(s) in Company
12th May 20204:41 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSNotice of AGM and Publication of Circular
27th Apr 20207:00 amRNSFinal Results
16th Apr 20207:00 amRNSUpdate on current trading and impact of COVID-19
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
4th Feb 202012:07 pmRNSSecond Price Monitoring Extn
4th Feb 202012:02 pmRNSPrice Monitoring Extension
8th Jan 20204:41 pmRNSSecond Price Monitoring Extn
8th Jan 20204:35 pmRNSPrice Monitoring Extension
16th Dec 20197:00 amRNSDirectorate Change
10th Dec 20193:48 pmRNSHolding(s) in Company
5th Dec 20193:52 pmRNSHolding(s) in Company
4th Nov 20194:41 pmRNSSecond Price Monitoring Extn
4th Nov 20194:36 pmRNSPrice Monitoring Extension
20th Sep 20197:00 amRNSInterim Results
25th Jun 201911:44 amRNSHolding(s) in Company
18th Jun 20194:40 pmRNSResult of AGM
26th Apr 20195:47 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSPreliminary Results
31st Jan 20194:41 pmRNSSecond Price Monitoring Extn
31st Jan 20194:36 pmRNSPrice Monitoring Extension
24th Jan 20199:07 amRNSHolding(s) in Company
23rd Jan 201911:06 amRNSHolding(s) in Company
11th Jan 20191:05 pmRNSDirector/PDMR Shareholding
28th Dec 20184:36 pmRNSPrice Monitoring Extension
6th Dec 20184:40 pmRNSSecond Price Monitoring Extn
6th Dec 20184:35 pmRNSPrice Monitoring Extension
27th Nov 20187:00 amRNSUpdate on the Kurt Salmon escrow funds
21st Nov 20184:41 pmRNSSecond Price Monitoring Extn
21st Nov 20184:35 pmRNSPrice Monitoring Extension
9th Nov 20184:40 pmRNSSecond Price Monitoring Extn
9th Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 20184:40 pmRNSSecond Price Monitoring Extn
2nd Nov 20184:35 pmRNSPrice Monitoring Extension
1st Oct 20181:28 pmRNSUpdate on the Kurt Salmon escrow funds
17th Sep 201811:19 amRNSDirector Declaration
17th Aug 20184:53 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSHalf-year Report
9th Aug 20184:40 pmRNSSecond Price Monitoring Extn
9th Aug 20184:35 pmRNSPrice Monitoring Extension
3rd Aug 20187:00 amRNSUpdate on the Kurt Salmon escrow funds
24th Jul 201812:55 pmRNSHolding(s) in Company
23rd Jul 20183:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.